/images/headbanner/23-HighPotencyAPI.jpg
High Potency API
Head Banner
One stop platform for high potency (HP) API from preclinical to commercial

WuXi STA has a one-stop HPAPI platform covering from process R&D to commercial manufacturing in Changzhou and Jinshan sites, China, providing a robust dual supply chain to our global customers. Our HPAPI platform includes a number of HP R&D labs, HP kilo labs, and 2 HP production plants that handle HP compounds with an OEL limit of 10 ng/m3.

Our HPAPI capability also includes HP milling for both wet & dry milling, including jet mill, pin mill and hammer mill. We also provide options for API production both in batch mode and flow mode. 

/media/151059/hpapi3000l.jpg
#EFEFEF
HQArticle_Head
High Potency Labs

Our HP labs include both R&D labs and Kilo GMP labs in Changzhou site and Jinshan site, supporting all common reactions with the reactor size up to 100L. We have both non-GMP and GMP production lines, as well as special lines for hydrogenation reaction and flow chemistry to meet different customer needs.  

/media/150668/图2硬质隔离器.jpg
#EFEFEF
HQArticle_Head
High Potency Plants

We have 2 HP production plants in Changzhou site, China, equipped with reactors size up to 3,000L, as well as large scale prep-HPLC and lyophilizers up to 10m2 to support large scale HPAPI manufacturing.

/media/150670/%E5%9B%BE4.jpg
#EFEFEF
HQArticle_Head
中文
EN
  • Home 首页
  • {{menu.Name}} {{menu.Name}}
      • {{twoMenu.Name}} {{twoMenu.Name}}
        • {{threeMenu.Name}} {{threeMenu.Name}}
          • {{fourMenu.Name}}
    • {{twoMenu.Name}}
  • Home 首页
  • EN 中文

{{item.headBannerTitle}}

  • Services & Solutions Overview
  • API Process Development & Manufacturing
  • Formulation Development & Manufacturing
  • WuXi TIDES (Oligonucleotide and Peptide CRDMO Services)
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Filing
  • About Us
  • Services and Solutions
  • News
  • Resources
  • Careers
  • Contact us

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

{{item.title}}

{{item.title}}

{{secondGrids.title}}

{{item.table.title}}

  • {{grid.text}}

{{item.table.title}}

  • {{grid.text}}

{{item.title}}

{{item.content}}

  • {{art.subTitle}}

{{item.title}}

{{item.leftContent.title}}

{{item.rightContent.title}}

{{fa.title}}

{{fa.subTitle}}

{{fa.title}}

{{fa.subTitle}}

{{item.title}}

{{item.content}}

{{fa.title}}

{{item.title}}

{{item.title}}

{{art.articleTitle}}

{{art.articleContent}}

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

  • About Us
  • News
  • Resource
  • Careers
  • Contact Us

Services & Solutions

  • API Process Development & Manufacturing
  • Drug Product Development & Manufacturing
  • WuXi TIDES (Oligonucleotide and Peptide CRDMO Services)
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Support
  • 关于我们
  • 新闻和活动
  • 资源中心
  • 职业发展
  • 联系我们

服务和解决方案

  • 原料药工艺研发与生产
  • 制剂工艺研发与生产
  • WuXi TIDES (寡核苷酸及多肽CRDMO服务)
  • 分析开发与质量控制
  • 全球申报事务药学支持

领英

药明康德

Copyright © 2020 STA Pharmaceutical Co. Ltd. Privacy Policy 隐私策略 Terms of Use 使用条款 沪公网安备 31011502018943号